Jens Vikse

Author information from the last article

Jens Vikse er revmatolog og senterleder for NorTrials klinisk immunologi. Han er overlege ved Stavanger universitetssjukehus og universitetslektor ved Universitetet i Stavanger. Han er styremedlem i Norsk revmatologisk forening og medlem av EULAR Education Committee.

Articles by Jens Vikse

NorTrials drives growth in Norwegian clinical trials

Peder Langeland Myhre,
Åslaug Helland,
Kjell-Morten Myhr,
Jan Gunnar Skogås,
Thomas Langø,
Rasmus Goll,
Jens Vikse,
Signe Øien Fretland

08.01.2026: NorTrials has helped increase the focus on clinical trials in Norway. NorTrials was established by Erna Solberg's government in 2022 as one of the initiatives in the National Action Plan for Clinical Trials. The initiative is a partnership between the specialist health service and the pharmaceutical...

IgG4-related disease

Jens Vikse,
Sven Håland,
Katrine Brække Norheim

04.09.2017: Immunoglobulin G subclass 4-related disease (IgG4-RD) is a relatively recently identified immune-mediated systemic disease characterised by inflammation and progressive fibrosis. The most common clinical manifestations are pancreatitis and sialadenitis, but the disease may affect virtually any organ...

A man in his 30s with ulcerative colitis and pancytopenia

Jens Vikse,
Daniel Limi Cacic,
Arne Carlsen,
Trond Johan Cooper,
Tore Grimstad

21.06.2016: A man in his 30s was hospitalised with suspected exacerbation of ulcerative colitis. An interdisciplinary assessment revealed a potentially life-threatening condition. A man with ulcerative colitis was acutely admitted to the Department of Gastroenterology owing to a deterioration in his general...